I agree that this site is using cookies. You can find further informations here.
X
Rizvi, Naiyer A
183  results:
Search for persons X
?
1

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Rizvi, Naiyer ; Ademuyiwa, Foluso O ; Cao, Z Alexander...
Journal for ImmunoTherapy of Cancer.  11 (2023)  3 - p. e005920 , 2023
Link: https://doi.org/10.1136/..
 
?
2

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremel..:

de Castro Jr., Gilberto ; Rizvi, Naiyer A. ; Schmid, Peter...
Journal of Thoracic Oncology.  18 (2023)  1 - p. 106-119 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Single-cell RNA sequencing reveals distinct T cell populati..:

Bukhari, Shoiab ; Henick, Brian S. ; Winchester, Robert J....
Cell Reports Medicine.  4 (2023)  1 - p. 100868 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Baseline Radiomic Signature to Estimate Overall Survival in..:

Dercle, Laurent ; Fronheiser, Matthew ; Rizvi, Naiyer A....
Journal of Thoracic Oncology.  18 (2023)  5 - p. 587-598 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Society for Immunotherapy of Cancer (SITC) checkpoint inhib..:

Tawbi, Hussein A ; Sullivan, Ryan J ; Feltquate, David...
Journal for ImmunoTherapy of Cancer.  11 (2023)  7 - p. e007309 , 2023
Link: https://doi.org/10.1136/..
 
?
6

Teaching an old dog new tricks: re-engineering IL-2 for imm..:

Sznol, Mario ; Rizvi, Naiyer
Journal for ImmunoTherapy of Cancer.  11 (2023)  1 - p. e006346 , 2023
Link: https://doi.org/10.1136/..
 
?
7

Safety, tolerability and efficacy of agonist anti-CD27 anti..:

Sanborn, Rachel E ; Pishvaian, Michael J ; Callahan, Margaret K...
Journal for ImmunoTherapy of Cancer.  10 (2022)  8 - p. e005147 , 2022
Link: https://doi.org/10.1136/..
 
?
8

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (uto..:

Hamid, Omid ; Chiappori, Alberto A ; Thompson, John A...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005471 , 2022
Link: https://doi.org/10.1136/..
 
?
9

Assessing Pathologic Response in Resected Lung Cancers: Cur..:

Saqi, Anjali ; Leslie, Kevin O. ; Moreira, Andre L....
JTO Clinical and Research Reports.  3 (2022)  5 - p. 100310 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Cemiplimab monotherapy for first-line treatment of advanced..:

Sezer, Ahmet ; Kilickap, Saadettin ; Gümüş, Mahmut...
The Lancet.  397 (2021)  10274 - p. 592-604 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Patient-Reported Outcomes with Durvalumab With or Without T..:

Garon, Edward B. ; Cho, Byoung Chul ; Reinmuth, Niels...
Clinical Lung Cancer.  22 (2021)  4 - p. 301-312.e8 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Phase II study of durvalumab plus tremelimumab as therapy f..:

Leighl, Natasha B ; Redman, Mary W ; Rizvi, Naiyer...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e002973 , 2021
Link: https://doi.org/10.1136/..
 
?
13

Neoadjuvant atezolizumab and chemotherapy in patients with ..:

Shu, Catherine A ; Gainor, Justin F ; Awad, Mark M...
The Lancet Oncology.  21 (2020)  6 - p. 786-795 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Synchronous Pulmonary Adenocarcinomas:

Saqi, Anjali ; Fernandes, Helen ; Sonett, Joshua R...
American Journal of Clinical Pathology.  154 (2020)  1 - p. 57-69 , 2020
Link: https://doi.org/10.1093/..
 
?
15

Establishing guidelines to harmonize tumor mutational burde..:

Merino, Diana M ; McShane, Lisa M ; Fabrizio, David...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000147 , 2020
Link: https://doi.org/10.1136/..
 
1-15